Addus HomeCare Corporation (ADUS)
3 Reasons Why Growth Investors Shouldn't Overlook Addus HomeCare (ADUS)
Addus HomeCare (ADUS) possesses solid growth attributes, which could help it handily outperform the market.
Should Value Investors Buy Addus HomeCare (ADUS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pick These 4 Stocks With Impressive Interest Coverage Ratios
DECK, BOOT, ADUS & ENSG's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Ahead of Addus HomeCare (ADUS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Addus HomeCare (ADUS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2024.
ADUS vs. CHE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Chemed (CHE). But which of these two stocks is more attractive to value investors?
ADUS or USPH: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH). But which of these two stocks offers value investors a better bang for their buck right now?
Are Medical Stocks Lagging Addus HomeCare (ADUS) This Year?
Here is how Addus HomeCare (ADUS) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
JMP Securities initiated coverage on Addus HomeCare Corp ADUS, a provider of home-based personal care and clinical services.
Addus HomeCare (ADUS) Upgraded to Buy: Here's What You Should Know
Addus HomeCare (ADUS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ADUS vs. ASTH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and Astrana Health, Inc. (ASTH). But which of these two stocks presents investors with the better value opportunity right now?
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physical Therapy (USPH). But which of these two stocks presents investors with the better value opportunity right now?
Addus HomeCare Corporation (ADUS) Q3 2024 Earnings Call Transcript
Addus HomeCare Corporation (NASDAQ:ADUS ) Q3 2024 Earnings Conference Call November 5, 2024 9:00 AM ET Company Participants Dru Anderson - Senior Partner-FINN Partners Dirk Allison - Chairman & Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President & Chief Operating Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Tao Qiu - Macquarie Scott Fidel - Stephens Jared Haase - William Blair Matthew Gillmor - KeyBanc Andrew Mok - Barclays Ryan Langston - TD Cowen Operator Good day, and welcome to the Addus HomeCare's Third Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode.
